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Abstract. 
 
The extensively glycosylated lysosome-asso-
ciated membrane proteins (LAMP)-2a, b, and c are de-
rived from a single gene by alternative splicing that pro-
duces proteins with differences in the transmembrane 
and cytosolic domains. The lysosomal targeting signals 
reside in the cytosolic domain of these proteins. 
LAMPs are not restricted to lysosomes but can also be 
found in endosomes and at the cell surface. We investi-
gated the subcellular distribution of chimeras com-
prised of the lumenal domain of avian LAMP-1 and the 
alternatively spliced domains of avian LAMP-2. Chi-
meras with the LAMP-2c cytosolic domain showed pre-
dominantly lysosomal distribution, while higher levels 
of chimeras with the LAMP-2a or b cytosolic domain 
were present at the cell surface. The increase in cell 
surface expression was due to differences in the recog-
nition of the targeting signals and not saturation of in-
tracellular trafficking machinery. Site-directed mu-
tagenesis defined the COOH-terminal residue of the 
cytosolic tail as critical in governing the distributions of 
LAMP-2a, b, and c between intracellular compart-
ments and the cell surface.
 
L
 
ysosome
 
-associated membrane proteins (LAMPs)
 
1
 
 are
major components of the lysosomal membrane.
Two structurally related classes of LAMPs, LAMP-1
and -2, occur in birds and mammals, encoded by separate
but evolutionally related genes. Both classes of LAMPs have
a large, extensively glycosylated lumenal/extracellular do-
main, a single transmembrane domain, and a short cytoso-
lic tail (for reviews see Fukuda, 1991; Peters and von Figura,
1994). Recently, multiple mRNAs have been identified for
the LAMP-2 class (Hatem et al., 1995; Konecki et al., 1995).
These mRNAs arise by alternative splicing of a single
transcript and encode LAMP-2 molecules with different
transmembrane and cytosolic domains (Gough et al., 1995).
The consensus targeting sequence, G-Y-X-X-hydro-
phobe, for delivery of the LAMPs to lysosomes resides in
the cytosolic tail (Williams and Fukuda, 1990; Mathews,
et al., 1992; Guarnier et al., 1993; Höning and Hunziker,
1995; Höning et al., 1996). LAMPs can reach the lysosome
via two intracellular routes: a “direct” pathway from the
 
trans
 
-Golgi network either to the late endosomes or di-
rectly to lysosomes (Green et al., 1987; Harter and Mell-
man, 1992; Hunziker and Geuze, 1996), or an “indirect”
pathway, which involves transport to early endosomes and
the cell surface, where rounds of exocytosis and endocyto-
sis may occur before delivery to lysosomes (Lippincott-
Schwartz and Fambrough, 1986, 1987; Nabi et al., 1991;
Carlsson and Fukuda, 1992; Mathews, et al., 1992; Akasaki
et al., 1995). The signals for both direct and indirect deliv-
ery are contained within the targeting sequence.
The relative amounts of LAMPs expressed at the cell
surface in the steady state appear to vary with cell type
and physiological state. Many cells have very low levels of
LAMPs at the cell surface; however, highly metastatic tu-
mor cells (Saitoh et al., 1992), activated macrophages (Ho
and Springer, 1983), strongly stimulated platelets (Feb-
braio and Silverstein, 1990; Silverstein and Febbraio, 1992),
and retinoic acid-induced embryonal carcinoma cells (Amos
and Lotan, 1990) show increased levels of LAMPs at the
cell surface. LAMPs expressed at the cell surface carry
complex oligosaccharide chains that bind to E-selectin
(Sawada et al., 1994) and galaptin (Inohara and Raz, 1994;
Woynarowska et al., 1994) and are substrates for cell sur-
 
face 
 
b
 
-1,4-galactosyltransferase (Maillet and Shur, 1993).
Thus, cell surface LAMPs may be important mediators of
cellular adhesion through interactions of their carbohy-
drate chains with carbohydrate receptors. Regulation of
the subcellular distribution of LAMPs between the plasma
membrane and the endocytic pathway may therefore be
crucial in control of LAMP-mediated cell–cell interactions.
Perhaps this is why two targeting routes are available to
LAMPs. In the study reported here, we explored the rela-
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tionship between LAMP targeting signals and subcellular
distribution.
The LAMP-2 splice variants have different transmem-
brane domains and cytosolic tails. These differences in-
clude different amino acids within the COOH-terminal
G-Y-X-X-hydrophobe sequence that participates in pro-
tein targeting. Previously we showed that the lysosomal
targeting signal in the cytosolic tail of each of the LAMP-2
variants is competent for the delivery of chimeric LAMP
proteins to lysosomes (Hatem et al., 1995). In this study we
tested the hypothesis that the differences in LAMP-2 tar-
geting signals affect the steady-state distribution of the
LAMP-2 variants in cells. We report that the steady state
levels of the LAMP-1/LAMP-2 chimeras at the cell sur-
face are different and that these differences are correlated
with differences in the LAMP-2 COOH-terminal targeting
signals.
 
Materials and Methods
 
Construction of Chimeras
 
Plasmids encoding the LAMP chimeras were created in the pCB6 vector,
which contains the human cytomegalovirus promoter for expression in
mammalian cells and the G418 resistance gene for selection in G418 me-
dium. Table I shows the regions of amino acid sequence difference among
the various chimeras, along with a schematic of the structure of the chime-
ras. All of the chimeras contain the lumenal domain of LAMP-1 up to the
position defined by the boundary between exons 8 and 9 in the LAMP
genes. The numbering of the amino acids in the chimeras starts with the
first amino acid after the cleaved signal sequence of LAMP-1. Each of the
first three chimeras in Table I has the transmembrane domain and the cy-
tosolic tail from a single LAMP-2 variant. To dissect which region of the
molecule is responsible for the differences in cellular distribution, the
cytosolic tails were switched on the L/2b/2b and L/2c/2c chimeras creating
L/2b/2c and L/2c/2b (Table I, chimeras 4 and 5). Four point mutations
were created in the LAMP-2b cytosolic tail in the context of the L/2b/2b
chimera to make the sequence more similar to the LAMP-2c tail (Table I,
chimeras 6–9). The four point mutants include R391 to Y, S396 to T, V397
to L, and a combination mutant containing S396 to T and V397 to L. Fi-
nally, the reciprocal point mutation at the COOH-terminal residue of
L396 to V was made in the L/2c/2c chimera (Table I, chimera 10).
Point mutations were created using the Quick Change kit (Stratagene,
La Jolla, CA), and the nucleotide sequences encoding the complete trans-
membrane and cytosolic tail of each chimera were confirmed by dideoxy
sequencing with the Sequenase kit (United States Biochemical, Cleve-
land, OH) or dye terminator automated sequencing with the Genetic An-
alyzer (Prism 310; ABI Adv. Biotechnologies, Columbia, MD). The “tail
switch” chimeras were constructed by generating a PCR product contain-
ing the desired sequence and splicing this sequence into the appropriate
 
plasmid between unique HpaI and XhoI restriction enzyme sites. The nu-
cleotide sequences of all subcloned PCR fragments were determined to
confirm the fidelity of each PCR product. All primers were synthesized in
the trityl-on mode with the DNA synthesizer (PCR-MATE; Applied Bio-
systems, Foster City, CA) and purified through oligo purification car-
tridges.
 
Cell Lines and Culture
 
Plasmids were introduced into mouse L cells using Lipofectin (Life Tech-
nologies, Inc., Gaithersburg, MD) with Optimem medium (5 
 
m
 
g DNA/
60-mm dish of 60% confluent cells). Stable cell lines were selected and
maintained in Dulbecco’s minimal essential medium (DMEM) with 10%
fetal calf serum and 1% gentamycin, supplemented with 400 
 
m
 
g/ml G418.
Expression of chimeric LAMPs was induced by treatment of the trans-
fected cells with 1 mM butyrate for 48 
 
6
 
 2 h, and the subcellular distribu-
tion of LAMPs in individual cell lines (designated with a number) was
characterized. To minimize the possibility that observed differences in LAMP
distribution were due to peculiarities of individual cell lines, entire dishes
of nonclonal transfected L cells (designated “pool”) were also assayed as a
single sample. Individual cell lines were heterogeneous in terms of expres-
sion level per cell and the number of positive cells, as judged by immuno-
fluorescence microscopy.
 
Chimera Detection and Quantification
 
The distribution of the LAMP chimeras was determined using a mono-
clonal antibody (mAb-CV24) against the lumenal domain of avian
LAMP-1, formerly called LEP100 (Lippincott-Schwartz and Fambrough,
1987). This antibody recognizes the lumenal/extracellular domain and will
bind to LAMP chimeras expressed on the surface of intact cells. Also, this
antibody can be radiolabeled with 
 
125
 
I without loss of activity, permitting
direct detection and quantification of the amount of the chimera ex-
pressed by the transfected cells.
Immunofluorescent labeling of permeabilized cells was performed, af-
ter fixation in 1% formaldehyde, with 2 
 
m
 
g/ml mAb-CV24 in Hanks’ bal-
anced salt solution, 20 mM Tris-Cl, pH 7.5, and 2% horse serum (H/T/HS)
supplemented with 0.1% saponin. The primary antibody was detected with
FITC-conjugated goat anti–mouse secondary antibody (Kirkegaard &
Perry, Gaithersburg, MD). Immunofluorescent labeling of intact cells was
performed, after fixation in 1% formaldehyde, with 2 
 
m
 
g/ml FITC-conju-
gated mAb-CV24 in H/T/HS without saponin.
Iodinated antibody binding was performed on permeabilized and intact
fixed cells. mAb-CV24 (100 
 
m
 
g) was iodinated by the Iodogen method
(Salicinski et al., 1981). Binding was performed, after fixation in 1% form-
aldehyde, with 2 
 
m
 
g/ml 
 
125
 
I–mAb-CV24 in H/T/HS with or without 0.1%
saponin. Nonspecific binding was measured in the presence of 25-fold ex-
cess cold mAb-CV24 in the presence and absence of saponin. Each sam-
ple was assayed in triplicate. Specific binding was calculated by subtract-
ing the nonspecific counts per minute from total counts per minute for
both permeabilized and intact conditions. The fraction of LAMP mole-
cules present at the cell surface was calculated by dividing the specific
 
Table I. Primary Structure of the LAMP Chimeras
 
Chimera
Amino acids
from LAMP-1 Amino acids from LAMP-2
 
L/2a/2a F1-V345
 
NKFSIAEDCSPEVDY.FIVP IAVGAALGGLVVLVIMAYFLG HKKHHNTGYEQF
 
L/2b/2b F1-V345
 
NKFSIAEECFADSDLNFLIP VAVGMALGFLIILVFISYIIG .RRKSRTGYQSV
 
L/2c/2c F1-V345
 
NKFSIAQECSLDDD.TILIP IVVGAALAGLIVIIVIAYIIG .RRKSYAGYQTL
 
L/2c/2b F1-V345
 
NKFSIAQECSLDDD.TILIP IVVGAALAGLIVIIVIAYIIG .RRKSRTGYQSV
 
L/2b/2c F1-V345
 
NKFSIAEECFADSDLNFLIP VAVGMALGFLIILVFISYIIG .RRKSYAGYQTL
 
L/2b/2b R391Y F1-V345
 
NKFSIAEECFADSDLNFLIP VAVGMALGFLIILVFISYIIG .RRKSYTGYQSV
 
L/2b/2b S396T F1-V345
 
NKFSIAEECFADSDLNFLIP VAVGMALGFLIILVFISYIIG .RRKSRTGYQTV
 
L/2b/2b V397L F1-V345
 
NKFSIAEECFADSDLNFLIP VAVGMALGFLIILVFISYIIG .RRKSRTGYQSL
 
L/2b/2b S396T, V397L F1-V345
 
NKFSIAEECFADSDLNFLIP VAVGMALGFLIILVFISYIIG .RRKSRTGYQTL
 
L/2c/2c L396V F1-V345
 
NKFSIAQECSLDDD.TILIP IVVGAALAGLIVIIVIAYIIG .RRKSYAGYQTL
 
Structure Lumenal/extracellular domain Transmembrane domain Cytoplasmic tail 
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counts per minute of 
 
125
 
I–mAb-CV24 bound in the absence of saponin by
the specific counts per minute bound in the presence of saponin.
 
Antibody Internalization Assay
 
The internalization of LAMP molecules expressed on the cell surface was
estimated by measuring the rate at which 
 
125
 
I-labeled mAb-CV24 bound
to LAMP molecules at the cell surface became resistant to removal from
the surface by acid stripping. Stable cell lines were plated in 6-well plates
at 5 
 
3
 
 10
 
5
 
 cells/well and induced with butyrate for 48 h. Cells were cooled
on wet ice, washed once with cold H/T/HS, and incubated for 4 h with 2 
 
m
 
g/ml
 
125
 
I–mAb-CV24 in H/T/HS. The cells were washed in 2 baths of ice cold
H/T/HS for 15 min each to remove unbound antibody. Cells were either
kept on wet ice or incubated at 37
 
8
 
C in prewarmed Hepes-buffered
growth medium for the indicated times. The medium was collected. The
surface antibody was stripped with ice cold 0.1 M acetic acid/1.5 M NaCl
for 30 min on wet ice and collected. Finally, the cells were extracted in 1 N
NaOH at room temperature to determine cell-associated antibody. The
media, acetic acid solutions, and NaOH extracts were counted in a 
 
g
 
counter. Nonspecific binding was determined from cultures handled iden-
tically, except that a 25-fold excess of unlabeled mAb-CV24 was included
in the 
 
125
 
I–mAb-CV24 binding solution. After corrections for nonspecific
binding, the percent of bound antibody that was internalized was calcu-
lated by dividing the NaOH-extracted counts by the total counts present
in the medium, acetic acid, and NaOH extract.
 
Quantification of Endogenous Mouse LAMP-1
 
Endogenous mouse LAMP-1 was detected with the monoclonal antibody
1D4B, a gift from Dr. J.T. August (The Johns Hopkins University School
of Medicine, Baltimore, MD). For immunofluorescence microscopy and
iodinated antibody binding, the cells were processed as described above
for detection and quantification of avian LAMP chimeras. The fraction of
endogenous mouse LAMP-1 expressed at the cell surface was determined
from binding experiments with 
 
125
 
I-labeled mAb-1D4B; the binding ex-
periments and calculations were analogous to those described above for
quantifying the distribution of the avian LAMP chimeras. mAb-1D4B was
used at a concentration of 10 
 
m
 
g/ml for both immunofluorescence micros-
copy and iodinated antibody binding assays. The binding assays were per-
formed in two independent experiments with duplicate samples for total
and nonspecific binding in the presence and absence of 0.1% saponin.
 
Results
 
Chimeric LAMPs Have Different Levels of
Surface Expression
 
To determine whether the variable domains of the LAMP-2s
could affect the levels of LAMP-2 expressed at the cell
surface, chimeras between LAMP-1 and the LAMP-2 vari-
ants were made (Table I, and Hatem et al., 1995). The no-
menclature for the chimeras is given in Table I. The first
letter, L, represents the lumenal/extracellular domain from
avian LAMP-1; the second characters, 2a, b, or c, repre-
sent the transmembrane domain from one of the avian
LAMP-2 variants; and the last characters indicate the cy-
tosolic tail domain of a LAMP-2 variant. For example, chi-
mera L/2a/2a has the lumenal domain of LAMP-1, the
transmembrane domain of LAMP-2a, and the cytosolic
tail of LAMP-2a. Point mutations in the cytosolic tail are
indicated by conventional notation. Chimeras in which the
lumenal/extracellular domain of LAMP-1 was attached to
the transmembrane and cytosolic domains of each of the
three LAMP-2 variants, a, b, and c were expressed in sta-
bly transfected mouse L cells, and 1 mM butyrate was used
to induce expression.
Although each of the LAMP-1/LAMP-2 chimeras was
capable of being targeted to lysosomes (Hatem et al.,
1995), differences in their levels of expression at the cell
surface were readily apparent in direct immunofluorescent
labeling of intact cells (Fig. 1). Cells expressing the L/2c/2c
chimera showed negligible levels of surface immunofluo-
rescent labeling, to the extent that it was difficult to iden-
tify positive expressing cells by direct immunofluorescence
labeling without permeabilization (Fig. 1 
 
f
 
). Cells expressing
the L/2a/2a chimeras were more variable in surface expres-
sion; some cell lines contained easily identifiable, positive
Figure 1. Immunofluores-
cent labeling of intact and
permeabilized L cells ex-
pressing the L/2a/2a, L/2b/2b,
or L/2c/2c chimera. Stable
lines of L cells expressing the
indicated chimera were in-
duced for 48 h. a and b are
L/2a/2a clone 19. c and d are
L/2b/2b clone 20. e and f are
L/2c/2c clone 2–12. Intact cells
(b, d, and f) were fixed and
incubated with directly con-
jugated fluorescein–mAb-
CV24. Permeabilized cells (a,
c, and e) were fixed and indi-
rectly labeled with mAb-CV24
in the presence of saponin
using fluorescein-conjugated
goat anti–mouse secondary
antibody. Bar, 10 mm. 
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cells (lines 19 and 20) while in other lines the cells were
considerably fainter in their immunofluorescence (line 10)
without permeabilization. Cells expressing the L/2b/2b chi-
mera showed the highest levels of surface expression (Fig.
1 
 
d
 
).
The ability to visualize the chimeras at the cell surface is
dependent on both the level of expression and the per-
centage of molecules at the cell surface. Therefore, the
amount of LAMP-1/LAMP-2 chimera at the cell surface
was quantified by 
 
125
 
I–mAb-CV24 binding to intact and
permeabilized cells. Several clonal cell lines and also non-
clonal pools expressing each chimera were analyzed (Ta-
ble II). When the data from the cell lines expressing each
chimera are pooled and compared, differences in levels of
expression of the chimeras at the cell surface are apparent
(Fig. 2). Cells expressing L/2a/2a show 3-fold higher levels
of surface expression than cells expressing L/2c/2c; while
cells expressing L/2b/2b show 4-fold higher levels of surface
expression than L/2c/2c.
 
Endogenous Mouse LAMP-1 Retains Its Intracellular 
Distribution in Cell Lines Expressing LAMP Chimeras
 
It has been shown in previous studies that overexpression
of LAMP molecules can appear to saturate the lysosomal
targeting mechanism and result in increased expression of
LAMPs, including endogenous LAMPs, at the cell surface
(Harter and Mellman, 1992; Uthayakumar and Granger,
1995; Marks et al., 1996). Therefore, it was important to
ascertain whether levels of expression achieved in the
present studies were sufficiently high to cause the misdi-
rection of endogenous LAMPs to the cell surface. As shown
in Fig. 3, the amount of endogenous mouse LAMP-1 at the
 
cell surface in mouse L cells is very low in nontransfected
and also transfected cells both in the presence and absence
of 1 mM butyrate. The amount of mouse LAMP-1 at the
cell surface in the cells under every condition (transfected,
nontransfected, treated with butyrate, or untreated) was
2–4%, as quantified by 
 
125
 
I-labeled mAb-1D4B binding.
In cells induced to express L/2b/2b (line 20) or L/2c/2c
(line 5) with 39 and 5% of chimera molecules at the sur-
face,  respectively (Table II), the endogenous mouse
LAMP-1 remains predominantly intracellular with only
3–4% of mouse LAMP-1 at the cell surface. This result in-
dicates that expression of the exogenous LAMP chimeras
is not so high as to perturb the targeting of endogenous
LAMP-1 molecules. Cells induced to express L/2b/2b (line 20)
and then double labeled for surface expression of L/2b/2b
with mAb-CV24 and mouse LAMP-1 with mAb-1D4B
show that the L/2b/2b (Fig. 4, 
 
d
 
 and 
 
f
 
) is much more abun-
dant than the mouse LAMP-1 at the cell surface (Fig. 4, 
 
c
 
and 
 
e
 
), indicating that the molecules are distributed differ-
ently within the L cells. L/2b/2b and mouse LAMP-1 colo-
calize in lysosomes in double-labeled permeabilized cells
(Fig. 4, 
 
a
 
 and 
 
b
 
).
As an additional line of evidence that saturation of a tar-
geting mechanism did not occur, there was no correlation
between the level of expression of a chimera and the frac-
tion of molecules at the cell sufrace. In most of the cell
lines, the average number of chimera molecules per ex-
pressing cell varied from 
 
z
 
50,000 to 
 
z
 
400,000. In one ex-
treme case, a line expressing 
 
z
 
1 
 
3
 
 10
 
6
 
 molecule/cell of a
chimera with the LAMP-2c cytosolic tail had only 2% of
the molecules at the cell surface. Thus, overexpression re-
sulting in mistargeting of molecules to the plasma mem-
brane was not a complication in our study.
 
Table II. Percent of LAMP-1/LAMP-2 Chimera Expressed at 
the Cell Surface
 
Chimera Cell line
 
n*
 
Average surface
expression (
 
%
 
)
 
‡
 
pool 3 7 
 
6
 
 1
L/2c/2c 1-23 3 10 
 
6
 
 2
42 8
52 4
2-12 5 4 
 
6
 
 1
2-5 3 3 
 
6
 
 2
L/2a/2a pool 2 21
6 3 14 
 
6
 
 4
8 3 14 
 
6
 
 1
10 3 9 
 
6
 
 2
19 4 26 
 
6
 
 4
20 3 21 
 
6
 
 2
23 3 17 
 
6
 
 5
L/2a/2a pool 3 26 
 
6
 
 7
6 3 13 
 
6
 
 5
9 3 17 
 
6
 
 2
11 3 25 
 
6
 
 7
14 3 28 
 
6
 
 7
20 5 39 
 
6
 
 15
24 4 27 
 
6
 
 7
 
*
 
n
 
 represents the number of independent experiments in which each sample was as-
sayed in triplicate.
 
‡
 
average per cell line 
 
6
 
 standard deviation; calculated from 
 
125
 
I-labeled mAb-CV24
binding to intact and permeabilized cells as described in Materials and Methods.
Figure 2. Quantification of the percent of L/2a/2a, L/2b/2b, and
L/2c/2c at the cell surface. Individual clones and pools of trans-
fected L cells were induced for 48 h. Percent of each chimera de-
tected at the cell surface with 125I-labeled mAb-CV24 was calcu-
lated as described in Materials and Methods. Data represent the
average and standard error for all individual clones and pools of
cells combined. 
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The Cytosolic Tail Determines Subcellular Distribution
 
To determine whether the differences in subcellular distri-
bution of the various LAMP chimeras were due to differ-
ences in the transmembrane domain or in the cytosolic tail,
“tail switch” chimeras (L/2b/2c and L/2c/2b) were con-
structed, and their subcellular distributions in transfected
mouse L cells were determined. As shown in Fig. 5, cells
expressing chimeras with the LAMP-2c cytosolic tail showed
a very low level immunofluorescent labeling at the cell
surface of intact cells while showing intense labeling after
permeabilization (Fig. 5, 
 
a
 
 and 
 
b
 
). Cells induced to express
the chimeras with the LAMP-2b cytosolic tail showed high
levels of surface expression, evidenced by immunofluores-
cent labeling of intact cells (Fig. 5, 
 
c
 
 and 
 
d
 
). Quantita-
tively, the L/2c/2b chimeras were expressed at 3.3-fold
higher levels at the cell surface than the L/2b/2c chimeras
(Table III).
Levels of cell surface expression of these tail switch chi-
meras (Table III) as well as the parent chimeras (Table II)
correlated well with the identity of the cytosolic tail. That
is, chimeras with the LAMP-2b cytosolic tail showed the
highest levels of cell surface expression, while those with
the LAMP-2c cytosolic tail showed much lower levels of
cell surface expression. The differences in cell surface ex-
pression between L/2b/2c and L/2c/2b are consistent with
the targeting information being part of the cytosolic tail
and may be attributable to differences in the G-Y-X-X-
hydrophobe motif of the COOH-terminal five amino acids
of LAMP-2b and c. The cytosolic tails of LAMP-2b and c
differ in only 4 of the 12 residues (Table I). Two of these
differences are in the G-Y-X-X-hydrophobe sequence.
 
The COOH-terminal Residue Influences LAMP 
Subcellular Distribution
 
To assess which amino acids within the cytosolic tails of
the LAMP-2 molecules are critical in conferring high or
low levels of surface expression, point mutations were cre-
ated in the cytosolic tails of the L/2b/2b and L/2c/2c chime-
ras. Amino acids in the cytosolic tail of LAMP-2b were
replaced with amino acids present in the LAMP-2c tail
Figure 3. Quantification of endogenous LAMP-1 and transfected
chimera at the cell surface. The distribution of mouse LAMP-1
was determined by 125I-labeled mAb-1D4B binding as described
in Materials and Methods. The distribution of L/2b/2b or L/2c/2c
was determined by iodinated mAb-CV24 binding as described.
Nontransfected L cells were tested with and without 48-h treat-
ment in 1 mM butyrate. Each condition was tested in at least two
independent experiments.
Figure 4. The distribution of
mouse LAMP-1 and L/2b/2b
in transfected mouse L cells.
Induced L/2b/2b (clone 20)
cells were fixed and immuno-
labeled, with or without per-
meabilization, with mAb-
1D4B against endogenous
mouse LAMP-1 and mAb-
CV24 against L/2b/2b, as in-
dicated in the figure. Cells in
a and c and b and d were la-
beled with directly conju-
gated rhodamine–mAb-1D4B
and fluorescein–mAb-CV24,
respectively. Permeabilized
cells (a and b) were fixed,
and antibodies were incu-
bated in the presence of sa-
ponin. Cells in e and f were
indirectly labeled with mAb-
1D4B followed by fluores-
cein-conjugated goat anti–rat
secondary antibody and then
labeled with mAb-CV24 fol-
lowed by rhodamine-conjugated goat anti–mouse secondary antibody. a, c, and f were photographed with rhodamine epifluorescence.
b, d, and e were photographed with fluorescein epifluorescence. Bar, 10 mm.The Journal of Cell Biology, Volume 137, 1997 1166
and vice versa. L cells expressing the chimeras containing
the point mutations were analyzed by immunofluores-
cence microscopy (Fig. 6) and quantitative antibody bind-
ing (Table IV). The first mutation L/2b/2b R391Y was out-
side the G-Y-X-X-hydrophobe targeting sequence. This
mutant showed high levels of surface expression similar to
its parent chimera L/2b/2b, suggesting that this residue was
not part of the signal for efficient lysosomal targeting of
LAMP-2c (Fig. 6 b, and Table IV). Two mutations were created in the G-Y-X-X-hydrophobe sequence of LAMP-2b
S396T and V397L. The L/2b/2b S396T mutant showed
high levels of surface expression, indicating that this resi-
due was not sufficient to confer more efficient lysosomal
targeting information to the LAMP-2b cytosolic tail (Fig.
6 d, and Table IV). However, the L/2b/2b V397L mutant
showed remarkably lower surface expression, similar to
that seen with the L/2c/2c chimera, suggesting that the
COOH-terminal residue is important for the high effi-
ciency of lysosomal targeting of LAMP-2c (Fig. 6 f, and
Table IV). The double mutant containing the S396T and
V397L mutations behaved as the V397L mutant with low
expression at the cell surface (Table IV). To confirm that
the COOH-terminal residue could dictate the relative lev-
els of surface expression of the LAMP-2 variants, one ad-
ditional chimera (L/2c/2c L396V) was generated which
changes the COOH-terminal leucine of LAMP-2c to a
valine, the COOH-terminal residue of LAMP-2b. (Note
that LAMP-2c is shorter by one amino acyl residue than
LAMP-2b; position 396 is the penultimate residue in
LAMP-2b but the COOH-terminal residue in LAMP-2c.)
This chimera was expressed at high levels at the cell sur-
Figure 5. Immunofluorescent labeling of mouse L cells express-
ing the tail switch chimeras. Intact (b and d) cells were fixed and
incubated with directly conjugated fluorescein–mAb-CV24. Per-
meabilized cells (a and c) were fixed and incubated in the pres-
ence of saponin with mAb-CV24 followed by fluorescein-conju-
gated goat anti–mouse secondary antibody. a and b are L/2b/2c
clone 12. c and d are L/2c/2b clone 10. Bar, 10 mm. Figure 6. Immunofluorescent labeling of mouse L cells express-
ing point mutants of L/2b/2b or L/2c/2c. Intact (b, d, f, and h) cells
were fixed and incubated with directly conjugated fluorescein–
mAb-CV24. Permeabilized cells (a, c, e, and g) were fixed and in-
cubated in the presence of saponin with mAb-CV24 followed by
fluorescein-conjugated goat anti–mouse secondary antibody. a
and b are L/2b/2b R391Y clone 5. c and d are L/2b/2b S396T
clone 6. e and f are L/2b/2b V397L clone 13. g and h are L/2c/2c
L396V clone 3. Bar, 10 mm.
Table III. Percent of the Tail Switch Chimera Expressed at the 
Cell Surface
Chimera Cell line n*
Average surface
expression (%)‡
L/2c/2b pool 2 40
10 3 24 6 3
2-10 3 36 6 4
L/2b/2c 11 2 9
12 2 15
16 2 6
17 2 15
18 2 12
19 2 10
21 2 6
*n represents the number of independent experiments in which each sample was as-
sayed in triplicate.
‡average per cell line 6 standard deviation; calculated from 125I-labeled mAb-CV24
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face (Fig. 6 h, and Table IV), consistent with the COOH-
terminal residue being the essential component of the sig-
nal for dictating relative surface expression of the LAMP-
2 variants in the steady state.
The average cell surface expression levels of all the cell
lines and populations expressing the LAMP-2b and c chi-
meras and point mutants are compared in Fig. 7. The chi-
meric molecules clearly segregate into two populations
based on their COOH-terminal residue: one with high lev-
els of surface LAMP in the steady state and one with low
levels of surface LAMP in the steady state. Cells express-
ing chimeras with a COOH-terminal leucine residue (L/2c/
2c; L/2b/2c; L/2b/2b V397L; L/2b/2b S396T, V397L) showed
4.6-fold lower levels of surface expression than cells ex-
pressing the chimeras with COOH-terminal valine (L/2b/
2b; L/2c/2b; L/2b/2b S396T; L/2b/2b R391Y; L/2c/2c L396V),
demonstrating that the COOH-terminal amino acid greatly
influences the subcellular distribution of LAMP-2 mole-
cules.
Chimeras with Increased Surface Expression
Show Decreased Rates of Internalization from the
Cell Surface
LAMPs can be internalized from the cell surface via clath-
rin-mediated endocytosis. To determine whether differ-
ences in the rates of internalization could contribute to the
increased surface expression of those chimeras containing
a COOH-terminal valine, the internalization rates of four of
the chimeras (L/2b/2b, L/2c/2c, L/2b/2b V397L, and L/2c/2c
L396V) were determined (Fig. 8). Cells expressing the
L/2c/2c chimera or the L/2b/2b V397L mutant chimera in-
ternalized iodinated mAb-CV24 with a half-time of z6
min, indicating that the cytosolic tails of these two chime-
ras can interact with the molecular machinery that medi-
ates endocytosis. These cells essentially cleared the surface
of the chimera during the 60 min incubation at 378C, sug-
gesting either that the endosomal pool of chimera mole-
cules was much larger than the surface pool or that most of
the endocytosed molecules were not being recycled back to
the cell surface. Cells expressing chimera L/2b/2b or L/2c/2c
L396V did not internalize iodinated mAb-CV24 efficiently,
indicating that valine in the COOH-terminal position im-
paired the ability of the cytosolic tail to be recognized by
the endocytic machinery. We suggest that the relatively
high levels of surface expression of the L/2b/2b and L/2c/2c
L396V chimeras are attributable, at least in part, to drasti-
cally decreased rates of endocytosis.
Discussion
LAMPs are not restricted to lysosomes but can also be
found within the endosomal system and at the plasma
membrane. Regulation of LAMP distribution among these
compartments has been noted for several cell types. For
example, macrophages (Ho and Springer, 1983) and plate-
lets (Febbraio and Silverstein, 1990; Silverstein and Feb-
braio, 1992) redistribute their LAMP-1 and -2 molecules
to the cell surface in high amounts upon stimulation. Addi-
tionally, the distribution of LAMPs is altered during the
formation of a confluent monolayer of MDCK cells (Nabi
and Rodriguez-Boulan, 1993), upon retinoic acid-induced
differentiation of embryonal carcinoma cells (Amos and
Lotan, 1990), and in highly metastatic tumor cells (Saitoh
et al., 1992). Frequently, the changes in LAMP distribu-
tion are accompanied by alterations in the glycosylation
pattern of the LAMPs, such as is seen in the metastatic tu-
mor cells (Saitoh et al., 1992) and the MDCK cells (Nabi
and Rodriguez-Boulan, 1993). The appearance of LAMPs
at the cell surface may result in changes in the adhesion
properties of cells, since LAMPs can interact with E-selec-
tin (Sawada et al., 1994) and galaptin (Inohara and Raz,
1994; Woynarowska et al., 1994). Thus, regulation of the
abundance of LAMP molecules at the cell surface may
play an important role in regulation of cellular adhesion.
The abundance of LAMPs at the cell surface may be gov-
erned not only by extracellular stimuli but also by which
isoform (LAMP-2a, b, or c) is being expressed.
As the results of this study demonstrate, LAMP-1/
LAMP-2 chimeras show differences in steady state distri-
bution that are attributable to amino acid differences in
the cytosolic tail domains of the splice variants of LAMP-2.
Cells expressing LAMP-1/LAMP-2c showed very low lev-
els of surface expression similar to the levels of LAMP-1,
as described for primary cultures of chicken embryo fibro-
blasts (Lippincott-Schwartz and Fambrough, 1986) and L
cells (Mathews et al., 1992) and MDCK cells transfected
with chicken LAMP-1 (Nabi et al., 1991). Cells expressing
LAMP-1/LAMP-2a or LAMP-1/LAMP-2b showed much
higher levels of surface expression, suggesting that the
steady state distribution may be influenced by the differ-
Table IV. Percent of LAMP-1/LAMP-2 Point Mutant Chimera 
Expressed at the Cell Surface
Chimera Cell line n*
Average surface
expression (%)‡
L/2b/2b S396T pool 2 40
3 3 44 6 9
6 3 45 6 9
L/2b/2b R391Y 4 2 40
52 3 1
62 2 8
82 3 6
14 2 24
17 2 32
19 2 29
23 2 44
L/2b/2b V397L pool 3 8 6 2
73 4   6  1
13 3 6 6 1
L2b/2b S396T, V397L pool 6 8 6 2
63 5   6  1
19 2 6
21 2 6
24 3 5 6 2
L/2c/2c L396V pool 5 22 6 2
32 2 1
12 2 28
*n represents the number of independent experiments in which each sample was as-
sayed in triplicate.
‡average per cell line 6 standard deviation; calculated from 125I-labeled mAb-CV24
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ent cytosolic tail sequences. Chimeras in which the cyto-
solic tails of LAMP-2b and c were switched and chimeras
with point mutations in the cytosolic tails of LAMP-2b and
c showed different levels of surface expression, demon-
strating that differences in subcellular distribution of
LAMP-2 splice variants can be attributed to differences in
their cytosolic tails. These results suggest that the LAMP-2
splice variants may have quantitatively different subcellu-
lar distributions in vivo and that the function of LAMP-2
molecules may be related, at least in part, to their expres-
sion at the plasma membrane.
It is possible that each LAMP has multiple functions
and that different functions involve different compart-
ments of the cell. Additionally, it is possible that each
LAMP variant plays a unique role in cells that express it.
Within the lysosome, the extensively glycosylated LAMPs
that accumulate in high abundance, such as LAMP-1 and -2c,
may provide a barrier to prevent degradation of the lyso-
somal membrane lipid bilayer and the lysosomal mem-
brane proteins that are important for lysosomal function.
On the other hand, the expression of LAMP molecules at
high levels in the plasma membrane, such as occurs with
LAMP-2a and b, as well as the redistribution of LAMPs to
the cell surface in certain situations, may provide opportu-
nities for interactions between LAMPs and receptors on
other cells or in the extracellular matrix. Such interactions
could influence cellular adhesion or participate in other in-
tercellular events. Less likely, but not excluded by present
information, LAMPs could be binding to extracellular com-
ponents which are then endocytosed together with the
LAMP molecules, the LAMP molecules essentially serv-
ing as receptors in receptor-mediated endocytosis.
Figure 7. Quantification of
the L/2b/2b and L/2c/2c
based chimeras at the cell
surface. Individual clones
and pools of transfected L
cells were induced with 1
mM butyrate for 48 h. Per-
cent of each chimera de-
tected at the cell surface with
125I-labeled mAb-CV24 was
calculated as described in
Materials and Methods. Data
represent the average and
standard error for each indi-
vidual clone and pool of cells
combined. The open bars
represent those chimeras
with a valine at their COOH-
terminal position. The shaded
bars represent those chime-
ras with a leucine at their
COOH-terminal position.
Figure 8. Endocytosis of chimeras from the cell surface. Individ-
ual clones of mouse L cells expressing chimeras L/2b/2b and L/2c/
2c and chimeras with COOH-terminal mutations L/2b/2b V397L
and L/2c/2c L396V were induced with 1 mM butyrate for 48 h.
The amount of internalization was calculated from the amount of
125I-labeled mAb-CV24 (initially bound to the cell surface at 48C)
that became resistant to stripping by low pH upon incubation at
378C. Each point is the average of two independent experiments
performed in triplicate except the zero time point, which repre-
sents the average value from all experiments. Clonal cell lines
tested were L/2b/2b 20, L/2c/2c 4, L/2b/2b V397L 7, and L/2c/2c
L396V 3. Curves for chimeras L/2c/2c and L/2b/2b V397L are fit
by first order exponentials with half-times of 6 min.Gough and Fambrough Subcellular Distribution of LAMP-2a, b, and c 1169
Mechanistically, the differences in subcellular distribu-
tion may reflect differences in the abilities of the cytosolic
tail targeting sequences to be recognized by intracellular
trafficking machinery. The G-Y-X-X-hydrophobe sequence
is believed to be recognized by adaptin complexes, AP-1 at
the  trans-Golgi network and AP-2 at the plasma mem-
brane (Ohno et al., 1995; Höning et al., 1996). Differences
within this G-Y-X-X-hydrophobe consensus sequence,
such as those seen among the LAMP-2 variants, may re-
sult in different affinities for the adaptin complexes at var-
ious steps in the biosynthetic/targeting pathway. Consis-
tent with this possibility, the chimeras with high surface
expression, such as L/2b/2b and L/2c/2c L396V, were
found to be deficient in their ability to be endocytosed
from the cell surface, suggesting that the AP-2 complex
may not efficiently recognize LAMP cytosolic tails that have
a valine in the COOH-terminal position. Such an infer-
ence is congruent with observations of Ohno et al. (1995)
that when the targeting sequence of TGN38 (SDYQRL)
was made COOH terminal, replacing the COOH-terminal
leucine with valine greatly decreased its interaction with
the AP-2 m subunit and to a lesser degree decreased its in-
teraction with the AP-1 m subunit, assessed in yeast two
hybrid assays. Differences in recognition of LAMP cytoso-
lic tails by intracellular trafficking machinery at the level
of the trans-Golgi network, the plasma membrane, and the
endosomal compartment may also contribute to the differ-
ences in subcellular distribution of LAMPs. Whatever the
critical sorting sites and molecular mechanisms, the iden-
tity of the COOH-terminal residue provides an important
signal to determine the subcellular distribution of the
LAMP-2 variants.
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